Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

"Our research reveals the potential for digenic inheritance—where two genes work together to cause disease—expanding our ...

Scientists have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...

While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.The discovery of this relationship can be traced back to ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Findings suggest a safe, inexpensive, and effective pathway for allergists to treat children who already tolerate at least ...

A study at Mount Sinai has shown that children with a high tolerance for peanuts can significantly increase their resistance ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

An AI software system trained to detect findings suspicious for fetal congenital heart defects significantly improved ...

Other developments include an exciting, soon-to-be-announced tool exclusively available to students at the Icahn School of Medicine at Mount Sinai. This initiative is poised to redefine how AI is ...